COX-2

  • Vanderbilt University

    ‘Challenge’ puts technology transfer ingenuity on display

    Members of the First Diagnostics team are, from left, Elizabeth Conrad, Michael Feldkamp, Ph.D., Hailey Verano, Samantha Sarett and, at far right, team leader Kelsey Beavers. Lawrence Marnett, Ph.D., and Md. Jashim Uddin, Ph.D., fifth and sixth from the right, developed the COX-2 inhibitor that could lead to a new… Read More

    Apr. 16, 2015